跳至主要内容
临床试验/NL-OMON36966
NL-OMON36966已完成不适用

Selection of Breast Cancer Patients with Low-risk Tumors using MR Imaging - Patient Risk based on Functional MRI/ PROFILE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 18 years or older
  • - Female patients
  • - Eligible for breast-conserving therapy

排除标准

  • - Any prior surgery or radiotherapy to the ipsilateral breast
  • - Patients planned for neoadjuvant chemotherapy
  • - Karnofsky score <= 70
  • - Pregnant or lactating women
  • - Contra-indications to MRI scanning
  • Contra-indications to injection of gadolinium based contrast agent

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

已完成
不适用
Epirubicin/Paclitaxel/Cyclophosphamide-Methotrexate-Fluorouracil (E-T-CMF) as adjuvant chemotherapy in high-risk patients with operable breast cancerCancer - BreastBreast Cancer
ACTRN12615000161527Hellenic Cooperative Oncology Group1,000
已完成
不适用
Investigation of the prognostic role of protein expression, mRNA levels, gene amplification and mutation of key cellular elements in patients with breast cancer treated with dose-dense sequential adjuvant chemotherapyCancer - BreastBreast Cancer
ACTRN12616001043426Hellenic Cooperative Oncology Group1,060
已完成
3 期
Epirubicin-Paclitaxel-Cyclophosphamide Methotrexate Fluorouracil (E-T-CMF) versus Epirubicin-Cyclophosphamide Methotrexate Fluorouracil (E-CMF) as adjuvant chemotherapy in high risk patients with operable breast cancer. A phase III study conducted by the Hellenic Cooperative Oncology Group (HE10/97)
ACTRN12611000506998Hellenic Cooperative Oncology Group600
已完成
不适用
Prevention of breast cancer in high risk women by monitoring microrna expression in nipple aspirate fluid.breast carcinoma100836241000629110006232breast cancer
NL-OMON44762niversitair Medisch Centrum Utrecht720
已完成
3 期
Clinically node negative breast cancer patients undergoing breast conserving therapy: Sentinel lymph node procedure versus follow-up. A Dutch randomized controlled multicentre trial.sentinel lymph node metastasessentinel lymph nodes1000629110006295breast cancer
NL-OMON54499Medisch Universitair Ziekenhuis Maastricht1,730